Primary Sclerosing Cholangitis - Pipeline Review, H2 2012 - New Market Report Now Available
Global Markets Direct's, 'Primary Sclerosing Cholangitis - Pipeline Review, H2 2012', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Primary Sclerosing Cholangitis, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Primary Sclerosing Cholangitis. Primary Sclerosing Cholangitis - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites,...
View full press release